AllergyTalk
AllergyTalk delivers the latest insights and evidence shaping allergy and immunology. In each bimonthly episode, leading experts break down the most impactful research and real-world takeaways from AllergyWatch®, a bimonthly publication summarizing key findings from 20 major journals in allergy and asthma.
AllergyTalk delivers the latest insights and evidence shaping allergy and immunology. In each bimonthly episode, leading experts break down the most impactful research and real-world takeaways from AllergyWatch®, a bimonthly publication summarizing key findings from 20 major journals in allergy and asthma.
Episodes
Sep 2, 2025
Sep 2, 2025
28 min
Dr. Shyam Joshi, MD, Associate Professor and Section Chief at Oregon Health & Science University and Associate Editor of AllergyWatch® and hosts Dr. Gerald Lee, MD, FACAAI and and Dr. Stanley Fineman, MD, MBA reviewed the May/June 2025 issue of AllergyWatch®.
Articles Reviewed:
Association of Allergy Specialty Care and Asthma Outcomes for Medicaid-Enrolled Children
Race-Specific and Race-Neutral Equations for Lung Function and Asthma Diagnosis in Black Children
Anaphylactic degranulation by mast cells requires the mobilization of inflammasome components
Read archived issues of AllergyWatch®.
Earn CME credit for listening to this episode! Free for College members!
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
To submit feedback, corrections, and suggestions, please email allergytalk@acaai.org!
Speaker Disclosures: Gerald Lee, MD: No relevant financial relationships with ineligible companies to discloseStanley Fineman, MD: No relevant financial relationships with ineligible companies to discloseShyam Joshi, MD: Advisor: Novartis; Speaker: Novartis; Consultant: Merida Bioscience
The American College of Allergy, Asthma & Immunology (ACAAI) is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Jun 26, 2025
Jun 26, 2025
29 min
Dr. Sarah Spriet, DO, Staff Allergist and Clinical Immunologist at Alexander T. Augusta Military Medical Center in Northern Virginia. She is also a Core Faculty member for the National Capital Consortium Allergy-Immunology fellowship training program and an assistant editor of AllergyWatch® and hosts Dr. Gerald Lee, MD, FACAAI and Dr. Stanley Fineman, MD, MBA reviewed the January/February 2025 issue of AllergyWatch®.
Articles Reviewed:
Persistent cat ownership and asthma in a longitudinal study of Puerto Rican youth
The SQ tree sublingual immunotherapy tablet is effective and well tolerated in children – A pivotal phase III trial
Awareness and application of United States food allergy prevention guidelines among pediatricians and other clinicians
Read archived issues of AllergyWatch®.
Earn CME credit for listening to this episode! Free for College members!
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
To submit feedback, corrections, and suggestions, please email allergytalk@acaai.org!
Speaker Disclosures:Gerald Lee, MD: No relevant financial relationships with ineligible companies to discloseStanley Fineman, MD: No relevant financial relationships with ineligible companies to discloseSarah Spriet, DO: No relevant financial relationships with ineligible companies to disclose
The American College of Allergy, Asthma & Immunology (ACAAI) is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Jun 18, 2025
Jun 18, 2025
25 min
Special Episode
ACAAI's Fellows-in-Training Committee leaders Dr. Kylie Jungles, MD and Dr. Amber Hardeman, MD, MPH, MBA sat down with ACAAI's Practice Management Committee chair Dr. Melinda Rathkopf, MD, MBA to discuss advice on landing your first position. Continuing the conversation from Part 1, in this episode, our experts cover how to narrow down your choices, make sense of contracts and negotiations, decide whether to involve a contract lawyer, and plan a smooth transition into your next chapter.
Earn CME credit for listening to this episode! Free for College members!
To submit feedback, corrections, and suggestions, please email allergytalk@acaai.org!
Speaker Disclosures:Amber Hardeman, MD, MPH, MBA: No relevant financial relationships with ineligible companies to discloseKylie Jungles, MD: No relevant financial relationships with ineligible companies to discloseMelinda Rathkopf, MD, MBA, FACAAI: No relevant financial relationships with ineligible companies to disclose
The American College of Allergy, Asthma & Immunology (ACAAI) is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Jun 18, 2025
Jun 18, 2025
20 min
Special Episode
ACAAI's Fellows-in-Training Committee leaders Dr. Kylie Jungles, MD and Dr. Amber Hardeman, MD, MPH, MBA sat down with ACAAI's Practice Management Committee chair Dr. Melinda Rathkopf, MD, MBA to share essential tips for fellows-in-training starting their job search. Learn how to choose the right practice setting, create a strategic job search plan, and interview with confidence.
Earn CME credit for listening to this episode! Free for College members!
To submit feedback, corrections, and suggestions, please email allergytalk@acaai.org!
Speaker Disclosures:Amber Hardeman, MD, MPH, MBA: No relevant financial relationships with ineligible companies to discloseKylie Jungles, MD: No relevant financial relationships with ineligible companies to discloseMelinda Rathkopf, MD, MBA, FACAAI: No relevant financial relationships with ineligible companies to disclose
The American College of Allergy, Asthma & Immunology (ACAAI) is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Jun 9, 2025
Jun 9, 2025
27 min
Special Episode
On May 16, 2025, the FDA issued an alert regarding a rare but serious side effect of severe pruritus after discontinuing long-term use of cetirizine and levocetirizine. In this episode, we’ll discuss the background of this important announcement and what it means for our patients!
Michael S. Blaiss, MD, Clinical Professor of Pediatrics at the Medical College of Georgia and past-president and former Executive Medical Director of the American College of Allergy, Asthma, and Immunology. He has been a consultant for multiple companies manufacturing second generation antihistamines. Dr. Blaiss was joined by host Dr. Gerald Lee, MD, FACAAI.
Resources:
FDA Drug Safety Communication on Cetirizine and Levocetirizine
ACAAI Advice on Speaking Points Regarding FDA Alert
Previous articles describing this side effect:
Unbearable Pruritus After Withdrawal of (Levo)cetirizine
Pruritus after discontinuation of cetirizine
Make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
To submit feedback, corrections, and suggestions, please email allergytalk@acaai.org!
The American College of Allergy, Asthma & Immunology (ACAAI) is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
May 29, 2025
May 29, 2025
23 min
Dr. Sarah Spriet, DO, Staff Allergist and Clinical Immunologist at Alexander T. Augusta Military Medical Center in Northern Virginia. She is also a Core Faculty member for the National Capital Consortium Allergy-Immunology fellowship training program and an assistant editor of AllergyWatch® and hosts Dr. Gerald Lee, MD, FACAAI and Dr. Stanley Fineman, MD, MBA reviewed the January/February 2025 issue of AllergyWatch®.
Articles Reviewed:
A novel syndrome of silent rhinovirus-associated bronchoalveolitis in children with recurrent wheeze
Effects of moderate- versus vigorous-intensity exercise training on asthma outcomes in adults
Human Neutrophils Couple Nitric Oxide Production and Extracellular Trap Formation in Allergic Asthma
Read archived issues of AllergyWatch®.
Earn CME credit for listening to this episode! Free for College members!
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
To submit feedback, corrections, and suggestions, please email allergytalk@acaai.org!
Speaker Disclosures:Gerald Lee, MD: No relevant financial relationships with ineligible companies to discloseStanley Fineman, MD: Researcher: Novartis, Aimmune, DBV; Speaker: GenentechSarah Spriet, DO: No relevant financial relationships with ineligible companies to disclose
The American College of Allergy, Asthma & Immunology (ACAAI) is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Mar 25, 2025
Mar 25, 2025
21 min
Dr. Iris Otani, MD, an associate professor of medicine at UCSF and an assistant editor of AllergyWatch® and hosts Dr. Gerald Lee, MD, FACAAI and Dr. Stanley Fineman, MD, MBA reviewed the November/December 2024 issue AllergyWatch®.
Articles Reviewed:
Frequencies and predictors of subcutaneous and intraosseous injection with 4 epinephrine autoinjector devices
Forecasting daily total pollen concentrations on a global scale
Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis
Read archived issues of AllergyWatch®.
Earn CME credit for listening to this episode! Free for College members!
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
To submit feedback, corrections, and suggestions, please email allergytalk@acaai.org!
Speaker Disclosures:Gerald Lee, MD: No relevant financial relationships with ineligible companies to discloseStanley Fineman, MD: Researcher: Novartis, Aimmune, DBV; Speaker: GenentechIris Otani, MD: Consultant: CSL Behring, Change Healthcare, Adivo Associates
The American College of Allergy, Asthma & Immunology (ACAAI) is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Mar 11, 2025
Mar 11, 2025
26 min
Dr. Iris Otani, MD, an associate professor of medicine at UCSF and an assistant editor of AllergyWatch® and hosts Dr. Gerald Lee, MD, FACAAI and Dr. Stanley Fineman, MD, MBA reviewed the November/December 2024 issue AllergyWatch®.
Articles Reviewed:
Effect of Azithromycin on Asthma Remission in Adults With Persistent Uncontrolled Asthma: A Secondary Analysis of a Randomized, Double-Anonymized, Placebo-Controlled Trial
Polyethylene glycol hypersensitivity, patient outcomes in a 7-year retrospective study
Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity
Read archived issues of AllergyWatch®.
Earn CME credit for listening to this episode! Free for College members!
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
To submit feedback, corrections, and suggestions, please email allergytalk@acaai.org!
Speaker Disclosures: Gerald Lee, MD: No relevant financial relationships with ineligible companies to discloseStanley Fineman, MD: Researcher: Novartis, Aimmune, DBV; Speaker: GenentechIris Otani, MD: Consultant: CSL Behring, Change Healthcare, Adivo Associates
The American College of Allergy, Asthma & Immunology (ACAAI) is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Jan 31, 2025
Jan 31, 2025
22 min
Dr. Vivian Hernandez Trujillo, MD, the Division Director of allergy/immunology at Nickalus Children’s Hospital and an assistant editor of AllergyWatch and hosts Dr. Gerald Lee, MD, FACAAI and Dr. Stanley Fineman, MD, MBA reviewed the July/August 2024 issue AllergyWatch.
Articles Reviewed:
The mental health burden of food allergies: Insights from patients and their caregivers from the Food Allergy Research & Education (FARE) Patient Registry
Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders
Bronchoconstriction damages airway epithelia by crowding-induced excess cell extrusion
The speakers have the following disclosures:
Dr. Lee has been a speaker for NovartisDr. Fineman has nothing to discloseDr. Hernandez Trujillo:Advisory Board: Aimmune, ARS, Bryn, Bayer, Enzyvant, Pfizer, Sanofi & Regeneron, TakedaConsultant: Pharming, KaleoSpeaker: CSL, Takeda, Kaleo
Read archived issues of AllergyWatch®.
Earn CME credit for listening to this episode! Free for College members!
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
To submit feedback, corrections, and suggestions, please email allergytalk@acaai.org!
The American College of Allergy, Asthma & Immunology (ACAAI) is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Jan 16, 2025
Jan 16, 2025
19 min
Welcome to Season Three of Allergytalk!
Today we are joined by Dr. Vivian Hernandez Trujillo, the Division Director of allergy/immunology at Nickalus Children’s Hospital and an assistant editor of Allergy Watch. We will be reviewing the July-August issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
For information about CME credit, head over to http://education.acaai.org/allergytalk
To read archived issues of AllergyWatch, head over to http://college.acaai.org/publications/allergywatch
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
IgE to cross-reactive carbohydrate determinants (CCD) in childhood: Prevalence, risk factors, putative origins.
Activation of basophils in children with food allergies by blood from donors ingesting the corresponding food.
Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
Please rate our podcast on Apple Podcasts!
Please give us feedback, corrections, and suggestions!
Email feedback to: allergytalk@acaai.org
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Today’s speakers have the following disclosures:
Dr. Lee has been a speaker for Novartis
Dr. Fineman has nothing to disclose
Dr. Hernandez Trujillo:
Advisory Board: Aimmune, ARS, Bryn, Bayer, Enzyvant, Pfizer, Sanofi & Regeneron, Takeda
Consultant/Speaker: Kaleo
Consultant: Allergy & Asthma Network, Pharming
Speaker: CSL, Takeda







